The minutes from the June 2014 DUSC meeting are now available on the PBS website. A link to the minutes of this meeting have been adeded to the following entries in MAESTrO:

• Adalimumab (Humira) for patients with plaque psoriasis (2009/1)
• Etanercept (Enbrel) for patients with plaque psoriasis (2006/1)
• Infliximab (Remicade) for patients with plaque psoriasis (2006/2)
• Ustekinumab (Stelara) for patients with plaque psoriasis (2009/3)
• Pazopanib hydrochloride (Votrient) for patients with renal cell carcinoma (2012/1)
• Sunitinib maleate (Sutent) for patients with renal cell carcinoma (2008/2)
• Zoledronic acid monohydrate (Zometa) for patients with bone metastases (2002/3, 2002/3)
• Denosumab (Xgeva) for patients with bone metastases (2011/2)
• Omalizumab (Xolair) for patients with severe allergic asthma (2010/E3)